We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+3.98%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$15.1B
AUM Growth
+$134M
(+0.89%)
Cap. Flow
-$3.91B
Cap. Flow
% of AUM
-25.89%
Top 10 Holdings %
Top 10 Hldgs %
18.53%
Holding
722
New
62
Increased
243
Reduced
170
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MetLife
MET
|
+$92.3M |
| 2 |
Microsoft
MSFT
|
+$73.7M |
| 3 |
ExxonMobil
XOM
|
+$73.7M |
| 4 |
Starbucks
SBUX
|
+$72.3M |
| 5 |
Procter & Gamble
PG
|
+$54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MLU
METLIFE, INC. COM EQUITY UNIT
MLU
|
+$130M |
| 2 |
SLB Ltd
SLB
|
+$108M |
| 3 |
UTX.PRA
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
|
+$82M |
| 4 |
Eaton
ETN
|
+$72.7M |
| 5 |
CELG
Celgene Corp
CELG
|
+$57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.08% |
| 2 | Technology | 11.12% |
| 3 | Healthcare | 9.42% |
| 4 | Consumer Discretionary | 8.48% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
26
DELISTED
Walgreens Boots Alliance
WBA
| $101M | 0.67% |
1,331,371
-454,350
| -25% | -$30.4M |
|
27
GE Aerospace
GE
$367B
| $98.8M | 0.65% |
815,461
+18,067
| +2% | +$2.22M |
|
28
Booking.com
BKNG
$138B
| $97.3M | 0.64% |
2,132,375
-10,600
| -0.5% | -$479K |
|
29
Stryker
SYK
$127B
| $96.3M | 0.64% |
1,020,779
+234,044
| +30% | +$20.8M |
|
30
Qualcomm
QCOM
$176B
| $95.6M | 0.63% |
1,286,417
-231,575
| -15% | -$16.9M |
|
31
Zimmer Biomet
ZBH
$17.7B
| $92.2M | 0.61% |
837,231
+242,975
| +41% | +$25.6M |
|
32
Mondelez International
MDLZ
$77.7B
| $91.5M | 0.61% |
2,519,997
-126,090
| -5% | -$4.59M |
|
33
Amazon
AMZN
$2.5T
| $89.3M | 0.59% |
5,752,320
-70,480
| -1% | -$1.1M |
|
34
Costco
COST
$415B
| $88.2M | 0.58% |
622,347
-249,700
| -29% | -$33.9M |
|
|
AMT.PRA
35
DELISTED
American Tower Corporation
AMT.PRA
| $85.9M | 0.57% |
747,631
-11,337
| -1% | -$1.25M |
|
36
State Street
STT
$50.9B
| $84.3M | 0.56% |
1,074,495
+37,414
| +4% | +$2.81M |
|
|
37
Procter & Gamble
PG
$343B
| $82.9M | 0.55% |
910,276
+613,976
| +207% | +$54M |
|
38
EOG Resources
EOG
$78B
| $82M | 0.54% |
890,111
-5,983
| -0.7% | -$557K |
|
39
Delta Air Lines
DAL
$55.9B
| $81.4M | 0.54% |
1,655,572
-252,154
| -13% | -$10.6M |
|
40
Cognizant
CTSH
$21.5B
| $80.8M | 0.53% |
1,534,130
-239,797
| -14% | -$12M |
|
41
Pfizer
PFE
$140B
| $80.5M | 0.53% |
2,722,426
+639,838
| +31% | +$18.3M |
|
42
Chevron
CVX
$388B
| $79.9M | 0.53% |
712,017
+123,367
| +21% | +$14M |
|
43
Regeneron Pharmaceuticals
REGN
$68.8B
| $79.6M | 0.53% |
194,125
-109,637
| -36% | -$43.1M |
|
|
CCI.PRA
44
DELISTED
Crown Castle International Corp.
CCI.PRA
| $78.2M | 0.52% |
758,960
+15,422
| +2% | +$1.59M |
|
|
SWU
45
DELISTED
STANLEY BLACK & DECKER INC CORP UNIT
SWU
| $77.3M | 0.51% |
560,862
-18,278
| -3% | -$2.45M |
|
46
RTX Corp
RTX
$287B
| $74.4M | 0.49% |
1,027,594
-53,412
| -5% | -$3.64M |
|
47
Boeing
BA
$165B
| $72.6M | 0.48% |
558,388
-4,417
| -0.8% | -$560K |
|
|
EXCU
48
DELISTED
Exelon Corporation
EXCU
| $71.6M | 0.47% |
1,364,150
-19,355
| -1% | -$1.02M |
|
49
Union Pacific
UNP
$183B
| $70.8M | 0.47% |
594,298
-471,899
| -44% | -$54.2M |
|
50
American International
AIG
$41.9B
| $70M | 0.46% |
1,249,285
-2,778
| -0.2% | -$149K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, Calamos Advisors held 722 positions worth $15.1B, up 0.89% from $15B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Calamos Advisors withdrew a net $3.91B in Q4 2014, closing 71 positions and reducing 170 holdings. Its most notable exit was METLIFE, INC. COM EQUITY UNIT, an estimated $130M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Northrop Grumman worth $29.4M.
- Calamos Advisors's largest Q4 2014 buy was Northrop Grumman: 199,438 shares worth $29.4M.
- Calamos Advisors added most to MetLife in Q4 2014, an estimated $92.3M increase.
- Calamos Advisors's biggest Q4 2014 reduction was SLB Ltd, cutting an estimated $108M.
- Calamos Advisors fully exited METLIFE, INC. COM EQUITY UNIT in Q4 2014, selling an estimated $130M.
- Calamos Advisors's ten largest holdings make up 19% of its $15.1B portfolio in Q4 2014.
- Calamos Advisors opened 62 new positions and closed 71 in Q4 2014.
- Calamos Advisors's portfolio value rose 0.89% quarter-over-quarter to $15.1B.
Based on Calamos Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.